Table of Contents Author Guidelines Submit a Manuscript
Anemia
Volume 2016 (2016), Article ID 2046535, 5 pages
http://dx.doi.org/10.1155/2016/2046535
Research Article

Sickle-Cell Disease Healthcare Cost in Africa: Experience of the Congo

1Clinical Hematology Unit, Brazzaville Teaching Hospital, Auxence Ickonga Avenue, P.O. Box 32, Brazzaville, Congo
2Pediatric Intensive Care Unit, Brazzaville Teaching Hospital, Brazzaville, Congo
3National Laboratory of Public Health, Brazzaville Teaching Hospital, Brazzaville, Congo

Received 8 December 2015; Accepted 10 January 2016

Academic Editor: Duran Canatan

Copyright © 2016 L. O. Ngolet et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organisation, Management of Birth Defects and Hemoglobin Disorders: Report of a Joint Who-March of Dimes Meeting, World Health Organization, Geneva, Switzerland, 2006.
  2. B. Modell and M. Darlison, “Global epidemiology of haemoglobin disorders and derived service indicators,” Bulletin of the World Health Organization, vol. 86, no. 6, pp. 480–487, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. D. C. Rees, T. N. Williams, and M. T. Gladwin, “Sickle-cell disease,” The Lancet, vol. 376, no. 9757, pp. 2018–2031, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. T. N. William and S. K. Obaro, “Sickle cell disease and malaria morbidity: a tale with two tails,” Trends in Parasitology, vol. 27, no. 7, pp. 315–320, 2011. View at Publisher · View at Google Scholar
  5. A. B. John, A. Ramlal, H. Jackson, G. H. Maude, A. W. Sharma, and G. R. Serjeant, “Prevention of pneumococcal infection in children with homozygous sickle cell disease,” British Medical Journal, vol. 288, no. 6430, pp. 1567–1570, 1984. View at Publisher · View at Google Scholar · View at Scopus
  6. M. H. Gaston, J. I. Verter, G. Woods et al. et al., “Prophylaxis with oral penicillin in children with sickle cell anemia,” The New England Journal of Medicine, vol. 314, no. 25, pp. 1593–1599, 1986. View at Publisher · View at Google Scholar
  7. A. B. Mpemba Loufoua, P. Makoumbou, J. R. Mabiala Babela et al., “Dépistage néonatal de la drépanocytose au Congo Brazzaville,” Annales de l'Université Marien Ngouabi, vol. 11, no. 5, pp. 21–25, 2010. View at Google Scholar
  8. Rapport: Evaluation du Secteur Pharmaceutique du Congo, OMS, Juillet, 2006.
  9. S. Lanzkron, C. Haywood Jr., J. B. Segal, and G. J. Dover, “Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea,” American Journal of Hematology, vol. 81, no. 12, pp. 927–932, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Davis, R. M. Moore Jr., and P. J. Gergen, “Cost of hospitalizations associated with sickle cell disease in the United States,” Public Health Reports, vol. 112, no. 1, pp. 40–43, 1997. View at Google Scholar · View at Scopus
  11. R. D. Moor, S. Charache, M. L. Terrin et al., “The costs of children with sickle cell anemia. Preparing for managed care,” Journal of Pediatric Hematology/Oncology, vol. 20, no. 6, pp. 528–533, 1998. View at Publisher · View at Google Scholar
  12. L. O. Ngolet, H. Ntsiba, and A. Elira Dokekias, “Le coût de la prise en charge hospitalière des crises drépanocytaires,” Annales de l'Université Marien Ngouabi, vol. 14, no. 5, pp. 14–19, 2013. View at Google Scholar
  13. E. Barett-Connor, “Bacterial infection and sickle cell anemia,” Medicine, vol. 50, pp. 94–112, 1971. View at Google Scholar
  14. J. R. Mabiala-Babela, T. Nkanza-Kaluwako, P. S. Ganga-Zandzou, S. Nzingoula, and P. Senga, “Causes d'hospitalisation des enfants drépanocytaires : influence de l'âge (C.H.U. de Brazzaville, Congo),” Bulletin de la Société de Pathologie Exotique, vol. 98, no. 5, pp. 392–393, 2005. View at Google Scholar
  15. G. R. Serjeant, “Mortality from sickle cell disease in Africa,” British Medical Journal, vol. 330, no. 7489, pp. 432–433, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. S. D. Grosse, I. Odame, H. K. Atrash, D. D. Amendah, F. B. Piel, and T. N. Williams, “Sickle cell disease in Africa. A neglected cause of early childhood mortality,” American Journal of Preventive Medicine, vol. 41, no. 6, supplement 4, pp. S398–S405, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Coulibaly, A. Konate, D. Done, and F. Bougoudogo, “Étude de la prescription des antibiotiques en milieu hospitalier malien,” Revue Malienne D'infectiologie et de Microbiologie, vol. 3, pp. 2–8, 2014. View at Google Scholar
  18. IFMT, “Antibiotiques dans les pays en développement,” MS.IFMT//M05, 2004.
  19. D. Diallo and G. Tchernia, “Sickle cell disease in Africa,” Current Opinion in Hematology, vol. 9, no. 2, pp. 111–116, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Elira Dokekias, “Etude analytique des facteurs d'aggravation de la maladie drépanocytaire au Congo,” Médecine d'Afrique Noire Électronique, vol. 43, no. 5, pp. 279–285, 1996. View at Google Scholar
  21. I. Diagne, G. M. Soares, A. Gueye et al., “Infections in Senegalese children and adolescent with sickle cell anemia presenting with severe anaemia in a malarious area,” Tropical Doctor, vol. 45, no. 1, pp. 55–58, 2000. View at Google Scholar
  22. A. I. Juwah, A. Nlemadim, and W. Kaine, “Clinical presentation of severe anemia in pediatric patients with sickle cell anemia seen in Enugu, Nigeria,” American Journal of Hematology, vol. 72, no. 3, pp. 185–191, 2003. View at Publisher · View at Google Scholar · View at Scopus